{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:30:21Z","timestamp":1794346221988,"version":"4.9.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novoheart","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1305-y","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T13:03:25Z","timestamp":1562591005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Correlation between frataxin expression and contractility revealed by in vitro Friedreich\u2019s ataxia cardiac tissue models engineered from human pluripotent stem cells"],"prefix":"10.1186","volume":"10","author":[{"given":"Andy On-Tik","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Zi-Ying","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Wai","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Yee","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"Lieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camie W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fphar.2014.00130","volume":"5","author":"A Martelli","year":"2014","unstructured":"Martelli A, Puccio H. Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. Front Pharmacol. 2014;5:130.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pharmthera.2007.06.014","volume":"116","author":"JM Gottesfeld","year":"2007","unstructured":"Gottesfeld JM. Small molecules affecting transcription in Friedreich ataxia. Pharmacol Ther. 2007;116(2):236\u201348.","journal-title":"Pharmacol Ther"},{"issue":"R1","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1093\/hmg\/ddq165","volume":"19","author":"S Schmucker","year":"2010","unstructured":"Schmucker S, Puccio H. Understanding the molecular mechanisms of Friedreich\u2019s ataxia to develop therapeutic approaches. Hum Mol Genet. 2010;19(R1):R103\u201310.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1305_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00246-008-9305-1","volume":"30","author":"A Kipps","year":"2009","unstructured":"Kipps A, Alexander M, Colan SD, Gauvreau K, Smoot L, Crawford L, et al. The longitudinal course of cardiomyopathy in Friedreich\u2019s ataxia during childhood. Pediatr Cardiol. 2009;30(3):306\u201310.","journal-title":"Pediatr Cardiol"},{"issue":"10","key":"1305_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0002-9149(97)89194-1","volume":"77","author":"F Casazza","year":"1996","unstructured":"Casazza F, Morpurgo M. The varying evolution of Friedreich\u2019s ataxia cardiomyopathy. Am J Cardiol. 1996;77(10):895\u20138.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1305_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1586\/erc.12.57","volume":"10","author":"DR Lynch","year":"2012","unstructured":"Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG. Management and therapy for cardiomyopathy in Friedreich\u2019s ataxia. Expert Rev Cardiovasc Ther. 2012;10(6):767\u201377.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijcard.2015.05.074","volume":"194","author":"F Weidemann","year":"2015","unstructured":"Weidemann F, Liu D, Hu K, Florescu C, Niemann M, Herrmann S, et al. The cardiomyopathy in Friedreich\u2019s ataxia - new biomarker for staging cardiac involvement. Int J Cardiol. 2015;194:50\u20137.","journal-title":"Int J Cardiol"},{"issue":"1\u20132","key":"1305_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","volume":"307","author":"AY Tsou","year":"2011","unstructured":"Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307(1\u20132):46\u20139.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1305_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1242\/dmm.010900","volume":"6","author":"A Hick","year":"2013","unstructured":"Hick A, Wattenhofer-Donze M, Chintawar S, Tropel P, Simard JP, Vaucamps N, et al. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich\u2019s ataxia. Dis Model Mech. 2013;6(3):608\u201321.","journal-title":"Dis Model Mech"},{"issue":"9","key":"1305_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00424-013-1414-x","volume":"466","author":"YK Lee","year":"2014","unstructured":"Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, et al. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Pflugers Arch. 2014;466(9):1831\u201344.","journal-title":"Pflugers Arch"},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ijcard.2015.11.101","volume":"203","author":"YK Lee","year":"2016","unstructured":"Lee YK, Lau YM, Ng KM, Lai WH, Ho SL, Tse HF, et al. Efficient attenuation of Friedreich\u2019s ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Int J Cardiol. 2016;203:964\u201371.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.18632\/aging.101247","volume":"9","author":"DE Crombie","year":"2017","unstructured":"Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, et al. Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging (Albany NY). 2017;9(5):1440\u201352.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"1305_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2016.02.011","volume":"18","author":"R Passier","year":"2016","unstructured":"Passier R, Orlova V, Mummery C. Complex tissue and disease modeling using hiPSCs. Cell Stem Cell. 2016;18(3):309\u201321.","journal-title":"Cell Stem Cell"},{"key":"1305_CR14","doi-asserted-by":"publisher","first-page":"895967","DOI":"10.1155\/2013\/895967","volume":"2013","author":"N Kawaguchi","year":"2013","unstructured":"Kawaguchi N, Hatta K, Nakanishi T. 3D-culture system for heart regeneration and cardiac medicine. Biomed Res Int. 2013;2013:895967.","journal-title":"Biomed Res Int"},{"issue":"9","key":"1305_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1242\/dmm.030320","volume":"10","author":"KO Brandao","year":"2017","unstructured":"Brandao KO, Tabel VA, Atsma DE, Mummery CL, Davis RP. Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies. Dis Model Mech. 2017;10(9):1039\u201359.","journal-title":"Dis Model Mech"},{"issue":"1","key":"1305_CR16","doi-asserted-by":"publisher","first-page":"e0146697","DOI":"10.1371\/journal.pone.0146697","volume":"11","author":"TJ Cashman","year":"2016","unstructured":"Cashman TJ, Josowitz R, Johnson BV, Gelb BD, Costa KD. Human engineered cardiac tissues created using induced pluripotent stem cells reveal functional characteristics of BRAF-mediated hypertrophic cardiomyopathy. PLoS One. 2016;11(1):e0146697.","journal-title":"PLoS One"},{"issue":"35","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.1016\/j.biomaterials.2013.07.039","volume":"34","author":"J Wang","year":"2013","unstructured":"Wang J, Chen A, Lieu DK, Karakikes I, Chen G, Keung W, et al. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. Biomaterials. 2013;34(35):8878\u201386.","journal-title":"Biomaterials."},{"issue":"1","key":"1305_CR18","doi-asserted-by":"publisher","first-page":"1602448","DOI":"10.1002\/adma.201602448","volume":"29","author":"Angie M. Y. Shum","year":"2016","unstructured":"Shum AM, Che H, Wong AO, Zhang C, Wu H, Chan CW, et al. A micropatterned human pluripotent stem cell-based ventricular cardiac anisotropic sheet for visualizing drug-induced arrhythmogenicity. Adv Mater. 2017;29(1):1602448.","journal-title":"Advanced Materials"},{"issue":"48","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1002\/adma.201103463","volume":"23","author":"A Chen","year":"2011","unstructured":"Chen A, Lieu DK, Freschauf L, Lew V, Sharma H, Wang J, et al. Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives. Adv Mater. 2011;23(48):5785\u201391.","journal-title":"Adv Mater"},{"issue":"2","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1096\/fj.13-228007","volume":"28","author":"IC Turnbull","year":"2014","unstructured":"Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee JJ, Xie C, et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2014;28(2):644\u201354.","journal-title":"FASEB J"},{"key":"1305_CR21","doi-asserted-by":"crossref","unstructured":"Cashman TJ, Josowitz R, Gelb BD, Li RA, Dubois NC, Costa KD. Construction of defined human engineered cardiac tissues to study mechanisms of cardiac cell therapy. J Vis Exp. 2016;(109):e53447.","DOI":"10.3791\/53447"},{"issue":"14","key":"1305_CR22","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1089\/scd.2013.0509","volume":"23","author":"Z Weng","year":"2014","unstructured":"Weng Z, Kong CW, Ren L, Karakikes I, Geng L, He J, et al. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev. 2014;23(14):1704\u201316.","journal-title":"Stem Cells Dev"},{"issue":"2","key":"1305_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/84818","volume":"27","author":"H Puccio","year":"2001","unstructured":"Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27(2):181\u20136.","journal-title":"Nat Genet"},{"issue":"5","key":"1305_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","volume":"88","author":"S Al-Mahdawi","year":"2006","unstructured":"Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S, et al. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics. 2006;88(5):580\u201390.","journal-title":"Genomics."},{"issue":"1\u20133","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","volume":"512","author":"CJ Miranda","year":"2002","unstructured":"Miranda CJ, Santos MM, Ohshima K, Smith J, Li L, Bunting M, et al. Frataxin knockin mouse. FEBS Lett. 2002;512(1\u20133):291\u20137.","journal-title":"FEBS Lett"},{"key":"1305_CR26","doi-asserted-by":"crossref","unstructured":"Chandran V, Gao K, Swarup V, Versano R, Dong H, Jordan MC, et al. Inducible and reversible phenotypes in a novel mouse model of Friedreich\u2019s Ataxia. Elife. 2017;6:e30054.","DOI":"10.7554\/eLife.30054"},{"issue":"2","key":"1305_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cardiores.2004.06.030","volume":"64","author":"S Goffart","year":"2004","unstructured":"Goffart S, von Kleist-Retzow JC, Wiesner RJ. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc Res. 2004;64(2):198\u2013207.","journal-title":"Cardiovasc Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1305-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:25:07Z","timestamp":1594077907000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1305-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1305-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GW, KDC, CWC, and RAL hold equities in Novoheart whose value may potentially be affected by the publication of this manuscript. AOTW, MS, MZYC, WWT, BG, SYM, and DKL declared that they have no competing interests. AM and JFN were employees of Pfizer Inc. at the time this work was carried out.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}